medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2012, Number 2

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2012; 29 (2)

Metabolic Syndrome Clinical Features in Obese Scholars in the City of Oaxaca, México.

Rosas-Sumano AB, Rodal-Canales FJ, Zarate-Aspiros R, Paz-Pacheco A

Language: Spanish
References: 28
Page: 65-71
PDF size: 55.87 Kb.


ABSTRACT

Introduction: Childhood obesity is a risk factor for early development of type 2 diabetes, dyslipidemia and hypertension, components of the metabolic syndrome (MS) associated with increased cardiovascular risk. The purpose of this study was to identify clinical characteristics of MS in obese children of Oaxaca México.
Material and Methods: 226 children of both sexes between 6 and 12 years old were studied, 113 with BMI ≥ 85 th percentile, and 113 with BMI ≤ 85 th percentile. Weight, height, BMI, blood pressure and waist circumference were determined. Acanthosis nigricans and postprandial capillary glucose were documented.
Results: Difference in the means of waist circumference, systolic and diastolic blood pressure among children with overweight and obesity and children with normal weight were observed. (P= 0.0001). In the obese group, acanthosis nigricans was documented in 76.1%, and hypertension in 31%. BMI correlated with waist circumference and with systolic and diastolic blood pressure (r= 0.913, 0.471 and 0.526), the waist circumference correlated with systolic and diastolic blood pressure (r= 0.493 and 0.553) (P= 0.0001). Using multinomial logistic regression analysis, abdominal obesity, hypertension, and acanthosis nigricans were identified as independent markers of obesity (P ‹ 0.05).
Conclusion: It is necessary to identify these clinical features of MS in children with overweight and obesity, which will enable early intervention in those at risk for SM and type 2 diabetes, thus preventing the multiple complications of these disorders.


REFERENCES

  1. 1.- Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and treatment of high Blood Cholesterol in adults ( Adult treatment Panel III) Bethesda, Md: National Heart, Lung and Blood Institute, May 2001 ( NIH publication No 01-3670 JAMA 2001 285: 2486-97.

  2. 2.- Alberti KG, Zimmet PZ. Definition, diagnosis, and classification of diabetes mellitus and its complication. Part l: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-53.

  3. 3.-Einhorn D, Reaven GM, Cobin RH. Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocrin Pract. 2003; 9: 237-52.

  4. 4.- Cokk S, Auinger P, Li C, Ford E, Metabolic Syndrome Rates in United States adolescents, from the National Health and Nutrition Examination Survey, The Journal of Pediatrics, 2008; 52, 2: 158-9.

  5. 5.- American Diabetes Association. Screening for Type 2.Diabetes. Diabetes Care, 2003; 26: S21- S24.

  6. 6.- Alberti KGMM, Zimmet PZ, Shaw JE. The metabolic syndrome in children and adolescents, Lancet 2007; 369:2059-2061

  7. 7.- Ford ES, Li C Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J Pediatr. 2008, 152, 2, 160-4.

  8. 8.- Ford ES, Giles WH, Dietz WH, Prevalence of metabolic syndrome among US adults: finding from the Third National Health and Nutrition Examination Survey JAMA 2002; 287: 356-9.

  9. 9.- Weiss, Dziura, Burget, Tamborlane,Taksali, Yeckel, et al. Obesity and the Metabolic Syndrome in Children and Adolescents. The New England Journal of Medicine. 2004; 23, 350: 2362-74.

  10. 10.- Ferranti S, Gauvreau K, Ludwing D, Neufeld E, Newburger J, Rifai N. Prevalence of metabolic syndrome in American Adolescent. Findings from the third National Health and Nutrition Examination Survey. Circulation, 2004;110: 2494-7.

  11. 11.- Ford E, Li Ch, Zhao G., Pearson W, Mokdad A. H., Prevalence of the Metabolic Syndrome Among U.S. Adolescents Using the Definition From the International Diabetes Federation Diabetes Care, 2008 ; 31: 587-9.

  12. 12.- Rodríguez Moran M, Salazar-Vásquez B, Violante R, et al Metabolic síndrome among children. Diabetes Care 2004: 27 2516-7.

  13. 13.- Halley-Castillo E, Borges G, Talavera J . Orozco R, Vargas- Alemán C, Huitrón-Bravo G, et al. Body Mass Index and the Prevalence of Metabolic Syndrome among Children and Adolescents in Two Mexican Populations. Journal of Adolescent Health. 2007; 40: 521-6.

  14. 14.- Marcos-Daccarett, Núñez Rocha, Salinas-Martínez, Santos-Ayarzagoitia. Obesity as risk factor for metabolic disorden en Mexican adolescentes 2005 Rev. Salud Publica 2007; 9(2): 180-93.

  15. 15.- Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL: Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109:45– 60

  16. 16.- Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist Circumference Percentiles in nationally representative samples of African-American, European-American, and Mexican-American Children and Adolescents J Pediatr 2004;145:439- 44.

  17. 17.- National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents Pediatrics 2004; 114(2): 555-76.

  18. 18.- Machaca A, Saúl J. Acantosis nigricans e hiperinsulinemia en niños y adolescentes obesos del Instituto Nacional de Salud del Niño. Paediatrica 2006 ;8: 64-7.

  19. 19.- American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care. 2003; 26: S21- S24.

  20. 20.- Foster-Powel K, Holt S, Brand Miller J. International table of glycemic index and glycemic load values 2002. Am J Clin Nutr 2002; 76: 5–56.

  21. 21.- Encuesta Nacional de Salud y Nutrición 2006. Instituto Nacional de Salud Pública. México DF pp 94-7.

  22. 22.- Hirschler V, Aranda C, Luján M, Maccalini G, Jadzinsky M. Can Waist Circumference identify Children with the Metabolic Syndrome. Arch. Pediatr. Adolesc.. Med 2005; 159:740-744

  23. 23.- Falkner B, Sadowski R. Hypertension in children and adolescents. Am J Hypertens 1995; 8:106S-110S.

  24. 24.- Steinber J, Daniels FR. Obesity, insulin resistance, diabetes and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension and Obesity in the Young Committee ( council on cardiovascular Disease in the Young, and the Diabetes Committee ( council on nutrition, physical activity and Metabolism) Circulation 2003; 107: 1448-53.

  25. 25.- Balas NM, Villanueva QA, Tawil DS, Schiffman SE, Surveza FA, Vadillo OF, Perichart PO..Estudio piloto para la identificación de indicadores antropométricos asociados a marcadores de riesgo de síndrome metabólico en escolares mexicanos. Bol Med Hosp Infant Mex 2008; 65: 100-9.

  26. 26.- Stuart CA. Gikinson CR, Smith MM, Bosma AM, Keenan BS, Nagamani M. Acanthosis nigricans as a risk factor for non insulin dependent diabetes Mellitus. Clin Pediat ( Phila) 1998 ; 37: 73-9.

  27. 27.-Vázquez Chávez C. Fisiopatología de la resistencia a la insulina. En: Síndrome de Resistencia a la insulina Graphimedic. México 2004; pp 37-55.

  28. 28.- Consensus Statement: childhood obesity. J. Clin. Endocrinol. Metab. 2005;.90: 1871-87.




2020     |     www.medigraphic.com